Use of Implantable Cardioverter Defibrillators Canada Lags Behind U.S

The use of life-saving implantable cardioverter defibrillators in Canada is rising, but it is still significantly less than that in the United States. Dr. David Birnie and colleagues from the University of Ottawa Heart Institute report that, between 1995 and 2003, the use of implantable cardiovert...

New Implantable Cardioverter Defibrillators to avoid unnecessary shocks

Dr. Andrew Grace and colleagues from Papworth Hospital and University of Cambridge with collaboration from Cameron Health of San Clemente has devised new Implantable cardioverter defibrillators, which are devised to detect shock waves // from the whole heart rather than part of the muscle. This new...

Combination therapy for patients treated with Implantable Cardioverter Defibrillator

Professor Stuart J. Connolly and his team from McMaster University in their clinical trial reported in the journal JAMA that a combination of Antiarrhythmic drugs such as amiodarone combined with beta blockers such as Sotalol // found to reduce the painful shocks in ventricular arrhythmia patients ...

Boston Scientific Announces Results for Second Quarter Ended June 30, 2009

...P EPS of $0.10) Increased worldwide sales of cardiac rhythm management (CRM) products 10 percent, including a 13 percent increase in implantable cardioverter defibrillator (ICD) sales Increased worldwide sales of drug-eluting stent (DES) systems 14 percent Maintained leadership position in world...

Implanted defibrillators: New recommendations for drivers with ICDs

... Patients with an Implantable cardioverter Defibrillator (ICD) have an ongoing risk of sudden incapacitation that might cause harm to others while driving a car. Driving restrictions are impos...

EUROPACE raises remote monitoring profile

...he Cardiocentre Ticino (Lugano, Switzerland). Cardiovascular implantable electronic devices (CIEDs) - which include cardiac pacemakers, implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy (CRT) devices, implantable cardiovascular monitors and implantable loop recorders - have now b...

Advanced Technologies Pump Growth Into European Cardiac Rhythm Management Market, Affirms Frost & Sullivan

...s of $3.4 billion in 2008 and is estimated to reach $7.3 billion in 2015. The following segments are covered in this research: pacemakers, implantable cardioverter defibrillators, cardiac resynchronisation devices and ablation catheters and pacing leads. If you are interested in a virtual brochure, which pro...

Implanted Defibrillators Boost Long-Term Survival

... Heart patients gained an extra year of life over 8 years of follow-up, study finds,,,, THURSDAY, May 14 (HealthDay News) --Implanted cardioverter defibrillators (ICDs) extend heart patients' lives even eight years after implantation, new research shows. The finding was to be presented Thursda...

Boston Scientific Announces European Approval and First Implants of New Defibrillation Lead System Designed to Simplify the Surgical Process

...implants of the Company's ENDOTAK RELIANCE(R) 4-SITE defibrillation lead system. Defibrillation leads are insulated wires that connect an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) to the heart and, when needed, deliver life-saving therapy. The ...

Patients Call for Continued FDA Preemption Authority

...is week from the University of Notre Dame , born with a congenital heart defect that severely worsened in high school. Olivia required an implantable cardioverter defibrillator (ICD) in 2005. The patients emphasized how critical it was for them to have access to devices when they needed them...

Cardioverter in Medical Technology

MADIT-CRT Trial Meets Primary Endpoint

...s) to be associated with a significant 29 percent reduction (p=0.003) in death or heart failure interventions when compared to traditional implantable cardioverter defibrillators (ICDs). High risk(1), asymptomatic or mildly symptomatic, New York Heart Association (NYHA) Class I and II(2) patients were enrolled i...

TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry

...nfections associated with implanted pacemakers and cardioverter defibrillators. AIGIS also securely holds a pacemaker (PM) or implantable cardioverter defibrillator (ICD) in order to create a stable en...tended to securely hold a pacemaker or implantable cardioverter defibrillator (ICD) in order to create a stable en...

New MADIT II Clinical Data Analysis Shows Long-Term Survival Benefit for Implantable Defibrillator Therapy

... BSX ) today announced that an analysis of long-term data from the MADIT II clinical study demonstrates that the life-saving benefits of implantable cardioverter defibrillator (ICD) therapy remain sustainable at eight years. This is the first time long-term data have been presented regarding the life-saving be...

Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials

...lyzes outcomes data from patients monitored by the LATITUDE(R) Patient Management system. Five-year survival rate data for patients using implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) were presented at the Heart Rhythm Society Scientific Sessions in ...

Implantable Defibrillators Lower Risk of Death in Older Heart Patients

...ion rapid access journal report: Study highlights: -- Implantable cardioverter defibrillators (ICDs) may reduce the risk of death by 30 percent in patient...thier patients. DALLAS, Jan. 14 /PRNewswire-USNewswire/ -- Implantable cardioverter defibrillators (ICDs) can improve survival in patients with heart damage --...

Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death

... (NYSE: BSX ) today announced CE Mark approval for its COGNIS(TM) cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN(TM) implantable cardioverter defibrillator (ICD). These devices represent entirely new platforms to treat heart failure and sudden cardiac death and are the result of a multi-year...

Cardioverter in Medical Products

Vitality DS VR

Description:... Implantable defibrillators are used to treat heart rhythms that are abnormally fast and life threatening. Implantable cardioverter defibrillators (ICDs) often are used to treat sudden cardiac death (SCD), and have been found to reduce the SCD mortality rate for these patients from...
Company:Guidant Corporation

VITALITY 2 DR

Description:... The Guidant VITALITY 2 implantable cardioverter defibrillators (ICDs) are designed to treat patients at risk for sudden cardiac death (SCD) due to arrhythmia. The size and physiologic shape of the V...
Company:Guidant Corporation

Vitality DS

Description:... Implantable defibrillators are used to treat heart rhythms that are abnormally fast and life threatening. Implantable cardioverter defibrillators (ICDs) often are used to treat sudden cardiac death (SCD), and have been found to reduce the SCD mortality rate for these patients from...
Company:Guidant Corporation

Cardioverter in Medical Dictionary

Implantable cardioverter

An implantable cardioverter -defibrillator (ICD) is a small battery-powered electrical impulse generator which is implanted in patients who are at risk of sudden cardiac death due to ventricular fibrillation. The device is... An implantable cardioverter defibrillator is used in patie...

Defibrillator

...ing blood around the body... An implantable cardioverter defibrillator is used in patients at risk for r...ut defibrillator and more! ... This implantable cardioverter defibrillator (ICD) monitors for and, if necess..., ... Help and Support For Heart ICD Pacemaker cardioverter Defibrillator Implant Recipients Families, Docto...

Cardioverter in Biological News

Targeted drug therapy prevents exercise-induced arrhythmias

... been limited to two medications beta blockers, often used at very high doses, and calcium channel blockers to control the arrhythmias. Implantable cardioverter defibrillators (ICDs) are placed in patients at high risk for sudden death, but ongoing arrhythmias can result in frequent stressful shocks. The Dut...

Fish oil -- helpful or harmful?

...rchers. In a systematic review of trials where patients with implantable cardioverter defibrillators used fish oil supplements, Dr. David Jenkins and Dr. Paul Do...with stable angina. The same may also be true for patients with implantable cardioverter defibrillators who have a history of ventricular tachycardia and who are no...

Are one-third of costly implanted heart devices unnecessary? New study suggests yes

... This year, Medicare will pay for tens of thousands of heart patients to have high-tech devices implanted in their chests. Called ICDs or implantable cardioverter defibrillators, the expensive devices are designed to shock damaged hearts back into rhythm and save patients from sudden cardiac death, which kills 3...

Engineered heart tissue offers insights into irregular heartbeats, defibrillator failure

...tially use them to identify those people for whom defibrillators are more likely to worsen abnormal heart rate, Bursac said. So-called implantable cardioverter defibrillators (ICD) monitor the timing of heartbeats and can deliver small or large shocks to correct arrhythmias. Such devices have become increasin...

New defibrillator signals doctor of patient's irregular heartbeat or device malfunction

...or if the device malfunctions, e.g., battery failure. When a patient's status changes, a built-in microchip of Biotronik's Lumos DR-T implantable cardioverter defibrillator (ICD) sends a signal to a satellite via a small transmitter that can be placed on a nightstand, worn on a belt or kept in a purse. In a...

Cardioverter in Biological Technology

Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System

... I heart failure patients. The international version of the LATITUDE system is compatible with the Company's wireless TELIGEN(R) implantable cardioverter defibrillator (ICD) and COGNIS(R) cardiac resynchronization therapy defibrillator (CRT-D), the world's smallest and thinnest high-energy devices. ...

Boston Scientific to Donate Cardiac Rhythm Management Devices to Heartbeat International for Implantation in Needy Patients

...fic Corporation (NYSE: BSX ) today announced that it has agreed to donate Cardiac Rhythm Management (CRM) devices, including pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices to Heartbeat International, a non-profit organization dedicated to providing CRM devices ...

Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions

...esentations from the MADIT II clinical trial and the ALTITUDE Clinical Science Program. These presentations will provide new insights for implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) patients. Schedule of Events (all times are Eastern Time) Tu...

Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business

...od and Drug Administration (FDA) approval for three products in its Cardiac Rhythm Management business. They are: -- The CONFIENT(TM) implantable cardioverter defibrillator (ICD), which helps protect patients at risk of sudden cardiac death -- The LIVIAN(TM) cardiac resynchronization therapy defibril...

Boston Scientific Announces Results for Third Quarter Ended September 30, 2007

... 54 percent last quarter - Reported year-over-year worldwide cardiac rhythm management (CRM) sales growth of 16 percent, including implantable cardioverter defibrillator (ICD) growth of 18 percent - Announced several new initiatives designed to increase shareholder value, including the planned s...

Boston Scientific Announces European Approval of Next-Generation Implantable Defibrillator

..., Mass., Oct. 9 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced CE Mark approval of its CONFIENT(TM) implantable cardioverter defibrillator (ICD). This approval represents the first Boston Scientific-branded cardiac rhythm management device to treat sudden cardiac death (SCD)...